Buy Mphasis Ltd for the Target Rs. 2,625 by Choice Institutional Equities
Key management meet takeaways:
We attended Mphasis’s Analyst Day and the key takeaways are: (1) Mphasis is repositioning itself as an AI-led, outcome-oriented enterprise transformation player, with the management viewing GenAI as a larger growth opportunity despite near-term deflation in legacy delivery; (2) Enterprise Agency emerged as the core theme, with focus on governed, explainable AI-led decisioning for regulated industries; (3) Launch of Mphasis Tria, an enterprise AI platform, which helps Mphasis’s transition toward platform-led, IP-driven transformation engagements; and (4) A gradual shift towards outcome-linked pricing and vendor consolidation-led wallet share gains, which supports better revenue quality and margin resilience over time. While monetisation remains an execution watchpoint, improving large-deal momentum reinforces confidence in the medium-term growth narrative. We maintain a ‘BUY’ on Mphasis with a TP of INR 2,625 on the basis of FY28E EPS.
AI-led Repositioning; Execution Key to Monetisation:
Mphasis is strategically repositioning from a traditional IT services vendor toward an AI-led, outcomedriven enterprise transformation player, aiming to monetise enterprise AI deployment and decision intelligence rather than competing in commoditising foundation model infrastructure. In our view, Mphasis is positioning itself to monetise AI deployment and enterprise decisioning rather than competing in commoditising foundation model infrastructure that is, a strategically superior and potentially more scalable positioning.
Enterprise Agency: Moving Beyond AI Automation to Governed Decision Intelligence:
The central theme of the event was the “Enterprise Agency”, where AI moves beyond automation to govern business decisions. The management highlighted that despite rising enterprise AI experimentation, measurable business outcomes remain limited due to concerns around explainability, governance, and workflow control. Mphasis aims to address this through governed AI-driven decisioning, predictive intelligence, and outcomefocused delivery, positioning the company strongly in regulated sectors such as BFSI, healthcare, and insurance where compliance and explainability remain critical barriers to AI adoption.
Mphasis Tria: Driving the Shift Towards Platform-Led Enterprise AI Transformation:
The key strategic announcement was Mphasis Tria, the company’s enterprise AI platform built across three layers that is, Insight (knowledge), Foresight (decision intelligence) and Execute (workflow orchestration). We view Tria as a key step in Mphasis’ transition toward a platform-led, IP-driven transformation model. Its focus on governed “Enterprise Agency” could help build differentiated capabilities in complex industries while improving client stickiness and wallet share over time.
Evolving Commercial Models and Deeper Strategic Client Mining:
Importantly, management highlighted an evolving commercial model shifting from traditional T&M contracts toward platform-led, managed service, and outcomelinked pricing structures, which could improve revenue quality, deepen account mining, and support better margin resilience over time. Additionally, Mphasis continues to pursue selective vendor consolidation within large blue-chip accounts to strengthen delivery control and improve positioning for large transformation deals, with management indicating meaningful scaling potential in select relationships over the next 2–3 years
Industry Shift: From Traditional IT Services to Platform-led AI Transformation:
From an industry perspective, Mphasis’ strategy reflects the broader shift in IT services from labour-arbitrage-led models toward platform-led, AI-driven, and outcome-oriented transformation, with a differentiated focus on governed AI solutions for regulated industries.
View:
We remain constructive on Mphasis’s medium-term positioning, with the ‘Analyst Day’ reinforcing a differentiated AI-led growth narrative supported by platformisation, regulated vertical focus and wallet-share expansion opportunities. That said, near-term monetisation, scalability of Trialed engagements and conversion of conceptual AI adoption into meaningful revenue remain key watchpoints. Sustained large-deal momentum and evidence of improving revenue quality will be critical for a structural re-rating.
For Detailed Report With Disclaimer Visit. https://choicebroking.in/disclaimer
SEBI Registration no.: INZ 000160131
